Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 268 papers

Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis

Arroyo V, Moreau R.

J Hepatol 2017, 66(2): 451–453

DOI: 10.1016/j.jhep.2016.10.012

Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure

Alcaraz-Quiles J, Titos E, Casulleras M, Pavesi M, López-Vicario C, Rius B, Lopategi A, de Gottardi A, Graziadei I, Gronbaek H, Ginès P, Bernardi M, Arroyo V, Clària J.

Hepatology 2017, 65(1): 202–216

DOI: 10.1002/hep.28896

The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray

Clària J, Arroyo V, Moreau R.

J Immunol 2016, 197(10): 3755–3761

DOI: 10.4049/jimmunol.1600818

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Bendtsen F, Coenraad M, Sperl J, Gines P, Moreau R, Arroyo V, Jalan R; CANONIC Study Investigators of the EASL-CLIF Consortium

J Hepatol 2016, 64(3): 574–582

DOI: 10.1016/j.jhep.2015.10.018

Neuroinflammation in liver disease: sessional talks from ISHEN

Wright G, Swain M, Annane D, Saliba F, Samuel D, Arroyo V, DeMorrow S, Witt A.

Metab Brain Dis 2016, 31(6): 1339–1354

DOI: 10.1007/s11011-016-9918-7

Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure

Clària J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, Amorós À, Titos E, Alcaraz-Quiles J, Oettl K, Morales-Ruiz M, Angeli P, Domenicali M, Alessandria C, Gerbes A, Wendon J, Nevens F, Trebicka J, Laleman W, Saliba F, Welzel TM, Albillos A, Gustot T, Benten D, Durand F, Ginès P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-CLIF Consortium and the European Foundation for the Study of Chronic Liver Failure (EF-CLIF).

Hepatology 2016, 64(4): 1249–1264

DOI: 10.1002/hep.28740

Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis

Fernández J, Acevedo J, Prado V, Mercado M, Castro M, Pavesi M, Arteaga M, Sastre L, Juanola A, Ginès P, Arroyo V.

Liver Int 2017, 37(3): 385–395

DOI: 10.1111/liv.13239

Prognostic value of C-reactive protein in cirrhosis: External validation from the CANONIC cohort

Cervoni JP, Amorós À, Bañares R, Luis Montero J, Soriano G, Weil D, Moreau R, Pavesi M, Thévenot T, Di Martino V; EASL-CLIF Consortium

Eur J Gastroenterol Hepatol 2016, 28(9): 1028–1034

DOI: 10.1097/MEG.0000000000000676

Signaling and immunoresolving actions of resolvin D1 in inflamed human visceral adipose tissue

Titos E, Rius B, López-Vicario C, Alcaraz-Quiles J, García-Alonso V, Lopategi A, Dalli J, Lozano JJ, Arroyo V, Delgado S, Serhan CN, Clària J.

J Immunol 2016, 197(8): 3360–3370

DOI: 10.4049/jimmunol.1502522

Brexit from current guideline recommendations?

Angeli P, Piano S, Arroyo V; International Club of Ascites

Gut 2016, 65(11): 1919

DOI: http://dx.doi.org/10.1136/gutjnl-2016-312422

Registered office

European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024